Applications for Leave

Decision Information

Pharmascience Inc. v. Bristol-Myers Squibb Canada Co, Bristol-Myers Squibb Holdings Ireland Unlimited Company and Pfizer Inc.

Collection Applications for Leave
Date 2023-03-30
Case number 40400
Status Dismissed
On appeal from Canada
Notes

SCC Case Information

Decision Content

No. 40400     

 

 

March 30, 2023

 

Le 30 mars 2023

 

 

 

 

BETWEEN:

 

Pharmascience Inc.

Applicant

- and -

 

Bristol-Myers Squibb Canada Co., Bristol‑Myers Squibb Holdings Ireland Unlimited Company and Pfizer Inc.

Respondents

 

 

ENTRE :

 

Pharmascience Inc.

Demanderesse

- et -

 

Bristol-Myers Squibb Canada Co., Bristol‑Myers Squibb Holdings Ireland Unlimited Company et Pfizer Inc.

Intimées

 

 

 

JUDGMENT

 

The application for leave to appeal from the judgment of the Federal Court of Appeal, Numbers A-31-21 and A-32-21, 2022 FCA 142, dated August 4, 2022 is dismissed with costs.

 

 

JUGEMENT

 

La demande d’autorisation d’appel de l’arrêt de la Cour d’appel fédérale, numéros A‑31‑21 et A-32-21, 2022 FCA 142, daté du 4 août 2022, est rejetée avec dépens.

 

 

 

J.S.C.C.

J.C.S.C.

 You are being directed to the most recent version of the statute which may not be the version considered at the time of the judgment.